CVS Health Corporation announced the early results of the previously announced cash tender offer and that it is amending the tender offer by increasing the aggregate principal amount to $2,049,919,000 from $2,000,000,000, of its 4.300% senior notes due 2028. The maximum amount represents the principal amount of the notes subject to the tender offer and excludes any accrued interest or early tender payment. The tender offer is being made upon the terms and subject to the conditions set forth in the offer to purchase, dated August 9, 2021 (as amended or supplemented from time to time, the offer to purchase), which sets forth a detailed description of the tender offer. The tender offer is open to all registered holders of the notes. The consideration to be paid in the tender offer for the notes validly tendered and expected to be accepted for purchase as described in the offer to purchase (the total consideration) will be determined at 9:00 a.m., New York City time, on August 23, 2021. As of 5:00 p.m., New York City time, on August 20, 2021 (the early tender date), as reported by D.F. King & Co. Inc., the tender and information agent for the tender offer, the principal amount of the notes listed in the table above have been validly tendered and not validly withdrawn. The withdrawal deadline of 5:00 p.m., New York City time, on August 20, 2021 has passed and, accordingly, notes validly tendered in the tender offer may no longer be withdrawn. The company expects to accept for purchase and make payment for notes validly tendered and not validly withdrawn at or prior to the early tender date on August 24, 2021 (the early settlement date), subject to proration. Because the aggregate principal amount of notes validly tendered exceeds the maximum amount, the company expects that it will accept validly tendered notes on a prorated basis in accordance with the offer to purchase. Because the company expects to accept for purchase the maximum amount of notes, no additional notes will be purchased pursuant to the tender offer after the early settlement date. As described in the offer to purchase, all notes tendered and not accepted for purchase will be promptly returned to the tendering holder's account. Holders of all notes validly tendered and not validly withdrawn at or prior to the early tender date and accepted for purchase are eligible to receive the total consideration, which includes the early tender payment of $30 per $1,000 principal amount of notes tendered at or prior to the early tender date (the early tender payment). In addition to the total consideration, holders of notes accepted for purchase will receive accrued and unpaid interest up to, but not including, the early settlement date (accrued interest). The company expressly reserves the right, in its sole discretion, subject to applicable law, to terminate the tender offer at any time prior to the expiration date. The tender offer is not conditioned on any minimum principal amount of notes being tendered but the tender offer is subject to certain conditions as described in the offer to purchase.